212 related articles for article (PubMed ID: 28828705)
1. Glucotoxicity promotes aberrant activation and mislocalization of Ras-related C3 botulinum toxin substrate 1 [Rac1] and metabolic dysfunction in pancreatic islet β-cells: reversal of such metabolic defects by metformin.
Baidwan S; Chekuri A; Hynds DL; Kowluru A
Apoptosis; 2017 Nov; 22(11):1380-1393. PubMed ID: 28828705
[TBL] [Abstract][Full Text] [Related]
2. Phagocyte-like NADPH oxidase (Nox2) promotes activation of p38MAPK in pancreatic β-cells under glucotoxic conditions: Evidence for a requisite role of Ras-related C3 botulinum toxin substrate 1 (Rac1).
Sidarala V; Veluthakal R; Syeda K; Vlaar C; Newsholme P; Kowluru A
Biochem Pharmacol; 2015 Jun; 95(4):301-10. PubMed ID: 25881746
[TBL] [Abstract][Full Text] [Related]
3. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells.
Moon JS; Karunakaran U; Elumalai S; Lee IK; Lee HW; Kim YW; Won KC
J Diabetes Complications; 2017 Jan; 31(1):21-30. PubMed ID: 27662780
[TBL] [Abstract][Full Text] [Related]
4. Exposure to chronic hyperglycemic conditions results in Ras-related C3 botulinum toxin substrate 1 (Rac1)-mediated activation of p53 and ATM kinase in pancreatic β-cells.
Sidarala V; Kowluru A
Apoptosis; 2017 May; 22(5):597-607. PubMed ID: 28220272
[TBL] [Abstract][Full Text] [Related]
5. Rac1-NADPH oxidase signaling promotes CD36 activation under glucotoxic conditions in pancreatic beta cells.
Elumalai S; Karunakaran U; Lee IK; Moon JS; Won KC
Redox Biol; 2017 Apr; 11():126-134. PubMed ID: 27912197
[TBL] [Abstract][Full Text] [Related]
6. RhoG-Rac1 Signaling Pathway Mediates Metabolic Dysfunction of the Pancreatic Beta-Cells Under Chronic Hyperglycemic Conditions.
Chundru SA; Harajli A; Hali M; Gleason N; Gamage S; Kowluru A
Cell Physiol Biochem; 2021 Apr; 55(2):180-192. PubMed ID: 33851799
[TBL] [Abstract][Full Text] [Related]
7. VAV2, a guanine nucleotide exchange factor for Rac1, regulates glucose-stimulated insulin secretion in pancreatic beta cells.
Veluthakal R; Tunduguru R; Arora DK; Sidarala V; Syeda K; Vlaar CP; Thurmond DC; Kowluru A
Diabetologia; 2015 Nov; 58(11):2573-81. PubMed ID: 26224100
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Prenylation Promotes Caspase 3 Activation, Lamin B Degradation and Loss in Metabolic Cell Viability in Pancreatic β-Cells.
Syeda KG; Kowluru A
Cell Physiol Biochem; 2017; 43(3):1052-1063. PubMed ID: 28968609
[TBL] [Abstract][Full Text] [Related]
9. EHT 1864, a small molecule inhibitor of Ras-related C3 botulinum toxin substrate 1 (Rac1), attenuates glucose-stimulated insulin secretion in pancreatic β-cells.
Sidarala V; Veluthakal R; Syeda K; Kowluru A
Cell Signal; 2015 Jun; 27(6):1159-67. PubMed ID: 25725286
[TBL] [Abstract][Full Text] [Related]
10. The Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36.
Yoon JS; Moon JS; Kim YW; Won KC; Lee HW
J Korean Med Sci; 2016 Apr; 31(4):547-52. PubMed ID: 27051238
[TBL] [Abstract][Full Text] [Related]
11. RACking up ceramide-induced islet β-cell dysfunction.
Kowluru A; Kowluru RA
Biochem Pharmacol; 2018 Aug; 154():161-169. PubMed ID: 29715450
[TBL] [Abstract][Full Text] [Related]
12. Friendly, and not so friendly, roles of Rac1 in islet β-cell function: lessons learnt from pharmacological and molecular biological approaches.
Kowluru A
Biochem Pharmacol; 2011 Apr; 81(8):965-75. PubMed ID: 21300027
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemic Conditions Promote Rac1-Mediated Serine536 Phosphorylation of p65 Subunit of NFκB (RelA) in Pancreatic Beta Cells.
Kowluru A; Gamage S; Hali M; Gleason N
Cell Physiol Biochem; 2022 Aug; 56(4):367-381. PubMed ID: 35981264
[TBL] [Abstract][Full Text] [Related]
14. Glucotoxic conditions induce endoplasmic reticulum stress to cause caspase 3 mediated lamin B degradation in pancreatic β-cells: protection by nifedipine.
Syeda K; Mohammed AM; Arora DK; Kowluru A
Biochem Pharmacol; 2013 Nov; 86(9):1338-46. PubMed ID: 23994168
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomics reveals novel interaction partners of Rac1 in pancreatic β-cells: Evidence for increased interaction with Rac1 under hyperglycemic conditions.
Damacharla D; Thamilselvan V; Zhang X; Mestareehi A; Yi Z; Kowluru A
Mol Cell Endocrinol; 2019 Aug; 494():110489. PubMed ID: 31202817
[TBL] [Abstract][Full Text] [Related]
16. Arf nucleotide binding site opener [ARNO] promotes sequential activation of Arf6, Cdc42 and Rac1 and insulin secretion in INS 832/13 β-cells and rat islets.
Jayaram B; Syed I; Kyathanahalli CN; Rhodes CJ; Kowluru A
Biochem Pharmacol; 2011 Apr; 81(8):1016-27. PubMed ID: 21276423
[TBL] [Abstract][Full Text] [Related]
17. Proteasome dysfunction mediates high glucose-induced apoptosis in rodent beta cells and human islets.
Broca C; Varin E; Armanet M; Tourrel-Cuzin C; Bosco D; Dalle S; Wojtusciszyn A
PLoS One; 2014; 9(3):e92066. PubMed ID: 24642635
[TBL] [Abstract][Full Text] [Related]
18. Potential roles of PP2A-Rac1 signaling axis in pancreatic β-cell dysfunction under metabolic stress: Progress and promise.
Kowluru A
Biochem Pharmacol; 2020 Oct; 180():114138. PubMed ID: 32634437
[TBL] [Abstract][Full Text] [Related]
19. Phagocyte-like NADPH oxidase promotes cytokine-induced mitochondrial dysfunction in pancreatic β-cells: evidence for regulation by Rac1.
Subasinghe W; Syed I; Kowluru A
Am J Physiol Regul Integr Comp Physiol; 2011 Jan; 300(1):R12-20. PubMed ID: 20943855
[TBL] [Abstract][Full Text] [Related]
20. Protein farnesylation-dependent Raf/extracellular signal-related kinase signaling links to cytoskeletal remodeling to facilitate glucose-induced insulin secretion in pancreatic beta-cells.
Kowluru A; Veluthakal R; Rhodes CJ; Kamath V; Syed I; Koch BJ
Diabetes; 2010 Apr; 59(4):967-77. PubMed ID: 20071600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]